A Randomized, Double-Blind, Parallel Control Study to Evaluate the Biosimilarity of QL1209 with Perjeta® in Healthy Male Subjects
Frontiers in Pharmacology（2022）
Key words
QL1209,pertuzumab,biosimilar,pharmacokinetics,safety,immunogenicity
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined